Vanda Pharmaceuticals (VNDA) Tax Rate (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,143.00 |
| Dec 31, 2025 | -29,207.00 |
| Sep 30, 2025 | -164.00 |
| Jun 30, 2025 | 100.00 |
| Mar 31, 2025 | -388.00 |
| Dec 31, 2024 | 1,054.00 |
| Sep 30, 2024 | -368.00 |
| Jun 30, 2024 | 737.00 |
| Mar 31, 2024 | 5,467.00 |
| Dec 31, 2023 | -25,812.00 |
| Sep 30, 2023 | 17,173.00 |
| Jun 30, 2023 | 83.00 |
| Mar 31, 2023 | 1,298.00 |
| Dec 31, 2022 | -1,166.00 |
| Sep 30, 2022 | 862.00 |
| Jun 30, 2022 | 1,667.00 |
| Mar 31, 2022 | -280.00 |
| Dec 31, 2021 | -973.00 |
| Sep 30, 2021 | 411.00 |
| Jun 30, 2021 | 636.00 |
| Mar 31, 2021 | -783.00 |
| Dec 31, 2020 | -433.00 |
| Sep 30, 2020 | 757.00 |
| Jun 30, 2020 | -3,919.00 |
| Mar 31, 2020 | 3,373.00 |
| Dec 31, 2019 | 74,515.00 |
| Sep 30, 2019 | -71,820.00 |
| Jun 30, 2019 | 182.00 |
| Mar 31, 2019 | -106.00 |
| Dec 31, 2018 | -198.00 |
| Sep 30, 2018 | -54.00 |
| Jun 30, 2018 | 198.00 |
| Mar 31, 2018 | 490.00 |
| Dec 31, 2017 | -446.00 |
| Sep 30, 2017 | -5.00 |
| Jun 30, 2017 | -21.00 |
| Dec 31, 2011 | 138.00 |
| Sep 30, 2011 | -12.00 |
| Jun 30, 2011 | -56.00 |
| Mar 31, 2011 | 20,337.00 |
| Dec 31, 2010 | 5,503.00 |
| Sep 30, 2010 | -25,119.00 |